Health Catalyst, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Health Catalyst, Inc. on November 9, 2021. The filing serves to announce the Company's financial results for the quarter ended September 30, 2021. The specific financial data is contained within a press release attached as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the referenced press release (Exhibit 99.1) rather than the body of this Form 8-K.
Material Changes
No material changes or comparative analysis versus prior periods are described within the text of this filing. Investors must refer to the attached press release for year-over-year or quarter-over-quarter performance data.
Guidance, Outlook, and Risks
This document does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. The filing explicitly states that the information is furnished and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, limiting its liability scope.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the quarter ended September 30, 2021.
- Verify the Company's stock trading symbol (HCAT) on The Nasdaq Global Select Market.
- Confirm the identity of the signatory, Bryan Hunt, Chief Financial Officer, who authorized the report.
- Note that the financial data in the press release is not deemed "filed" under Section 18 of the Exchange Act within this specific 8-K document.